Your trusted destination for CME, CPD & Medical Education across the Middle East.
Cleveland Clinic Learner College of Medicine of Case Western Reserve University
Feras Bader is a cardiologist and advanced heart failure and transplantation specialist with extensive clinical, academic, research, and leadership experience in the United States and the Middle East. His expertise is particularly focused on advanced heart failure, heart transplantation, ventricular assist devices (VADs), hemodynamics, and cardiorenal interactions. He has played a major role in developing advanced heart-failure and transplant services in the UAE and has held senior academic and clinical positions at the University of Utah and Cleveland Clinic Abu Dhabi.
Prof. Bader is a Clinical Professor of Medicine and Cardiology at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He specializes in Advanced Heart Failure and Transplantation and has been closely associated with Cleveland Clinic Abu Dhabi's Heart, Vascular & Thoracic Institute.
He has also served as Director of the Section of Advanced Heart Failure and Transplantation at Cleveland Clinic Abu Dhabi. His work in Abu Dhabi has centered on developing multidisciplinary advanced heart-failure and transplant services in the region.
| StageInstitution / Qualification | |
| Medical degree | University of Jordan School of Medicine, Amman, Jordan |
| Internal Medicine Residency | Yale University School of Medicine system |
| Heart Failure & Transplant Fellowship | Yale University School of Medicine system |
| Cardiovascular Fellowship | University of Utah School of Medicine |
| Master's degree | Master of Science in Clinical Investigation, University of Utah |
| Executive education | Executive MBA, University of Oxford |
| Board certifications | Internal Medicine, Cardiovascular Diseases, Echocardiography, Advanced Heart Failure & Transplant Cardiology |
Prof. Bader graduated from the University of Jordan School of Medicine in 1998. He subsequently completed his Internal Medicine residency and Heart Failure & Transplant fellowship through the Yale University School of Medicine system. He then moved to the University of Utah, where he completed cardiovascular fellowship training in 2006 and obtained a master's degree in Clinical Investigation.
In 2024, he completed an Executive Master of Business Administration from the University of Oxford, adding formal business and leadership training to his clinical and academic background.
After completing his cardiovascular fellowship in 2006, Prof. Bader joined the Division of Cardiology at the University of Utah. He subsequently became Medical Director of the Heart Failure Program at University of Utah Hospital and Director of the Advanced Heart Failure and Transplant Fellowship Program.
During his time at Utah, he developed expertise in advanced heart failure and transplantation while becoming involved in clinical investigation and cardiovascular research.
Before establishing his program in Abu Dhabi, Prof. Bader was also involved in helping establish an advanced heart failure program for the Kuwait Ministry of Health, giving him experience in developing specialized cardiovascular services within the Gulf region.
In 2015, Prof. Bader joined Cleveland Clinic Abu Dhabi with the objective of developing an internationally recognized advanced heart-failure and transplantation program in the Middle East.
During his decade at Cleveland Clinic Abu Dhabi, he helped establish what conference sources describe as the first multidisciplinary advanced heart-failure and transplant program of its kind in the UAE, incorporating therapies including artificial heart pumps and heart transplantation.
He also served in senior departmental leadership, including Vice Chairman and subsequently Chairman of the Department of Cardiovascular Medicine at Cleveland Clinic Abu Dhabi.
One of Prof. Bader's most significant professional contributions has been his role in establishing and developing advanced heart-failure and transplantation services in the UAE. His program incorporated a broad spectrum of advanced therapies, including mechanical circulatory support and heart transplantation.
His clinical career has been strongly associated with the development of heart-transplant capabilities in the UAE and the broader Middle East. His work has helped expand access to advanced therapies for patients with end-stage heart failure.
At the University of Utah, he served as Medical Director of the Heart Failure Program and Director of the Advanced Heart Failure and Transplant Fellowship Program.
Prof. Bader has held leadership roles in international cardiovascular organizations and regional educational initiatives. A 2024 conference biography identified him as Regional Chairman of the International Society for Heart and Lung Transplantation Foundation for the Middle East and Ambassador for the Heart Failure Society of America to the Middle East.
The ISHLT Foundation also lists him as Middle East Region Chair of its Global Steering Committee for 2022–2024.
He has been a Fellow of the American College of Cardiology (FACC) and has participated in ACC educational activities in the Middle East. In 2018, he chaired the ACC Middle East Conference, including sessions focused on contemporary heart-failure management.
Prof. Bader has served as a team leader for the American College of Cardiology's Global Physician Heart Failure Education program, contributing to international educational content covering advanced heart-failure therapies, cardiogenic shock, ventricular assist devices, heart transplantation, and other areas of specialist care.
His research interests are concentrated in several major areas:
He has participated in single-center and multicenter clinical trials and has published extensively in peer-reviewed medical literature. A recent conference biography reports more than 175 papers and abstracts.
A 2025 international review on innovations in heart-failure care lists Prof. Bader among its authors and identifies his institutional affiliation with the Heart and Vascular Institute, Cleveland Clinic Abu Dhabi.
One example of his research is work examining the hemodynamic effects of arteriovenous shunts in patients with heart failure with preserved ejection fraction, published in Cardiac Failure Review.

MeetingMinds Experts
MeetingMinds Experts

Middle East Heart Academy (MEHA)
Middle East Heart Academy (MEHA)